NCT02572323: A reported trial by University of California, San Diego
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02572323 |
|---|---|
| Title | Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 15, 2017 |
| Completion date | Oct. 15, 2023 |
| Required reporting date | Oct. 14, 2024, midnight |
| Actual reporting date | Oct. 15, 2024 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |